Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,240 | 162 | 98.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60.64 | 2 | 1.4% |
| Education | $12.16 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $502.64 | 57 | $0 (2023) |
| GENZYME CORPORATION | $483.43 | 12 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $361.26 | 8 | $0 (2024) |
| EMD Serono, Inc. | $313.64 | 6 | $0 (2021) |
| ARGENX US, INC. | $295.08 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $236.21 | 2 | $0 (2024) |
| Allergan, Inc. | $231.71 | 6 | $0 (2021) |
| AbbVie Inc. | $187.21 | 7 | $0 (2021) |
| Silk Road Medical, Inc. | $133.12 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $131.86 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $596.05 | 5 | ARGENX US, INC. ($216.33) |
| 2023 | $328.66 | 4 | AstraZeneca Pharmaceuticals LP ($124.61) |
| 2022 | $224.77 | 4 | Alexion Pharmaceuticals, Inc. ($81.43) |
| 2021 | $445.22 | 6 | Allergan, Inc. ($190.65) |
| 2020 | $90.06 | 5 | ACADIA Pharmaceuticals Inc ($29.77) |
| 2019 | $740.61 | 34 | Biogen, Inc. ($193.04) |
| 2018 | $617.09 | 22 | GENZYME CORPORATION ($124.50) |
| 2017 | $1,271 | 85 | Biogen, Inc. ($255.26) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Silk Road Medical, Inc. | ENROUTE Transcarotid Neuroprotection System (Device), ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent | Food and Beverage | In-kind items and services | $133.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/27/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 10/25/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $91.33 | General |
| Category: Immunology | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $111.60 | General |
| Category: Rare Disease | ||||||
| 09/10/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 11/02/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.61 | General |
| Category: Rare Disease | ||||||
| 10/12/2023 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $89.94 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 04/11/2023 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $97.02 | General |
| Category: Neurology | ||||||
| 03/23/2023 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Neurology | ||||||
| 10/04/2022 | Abbott Laboratories | AMPLATZER (Device) | Food and Beverage | In-kind items and services | $52.43 | General |
| Category: Structural Heart | ||||||
| 09/22/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Education | In-kind items and services | $12.16 | General |
| Category: Migraine | ||||||
| 08/31/2022 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $78.75 | General |
| Category: Immunology | ||||||
| 04/20/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $81.43 | General |
| Category: Rare Disease | ||||||
| 12/18/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $88.43 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/18/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $66.98 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/18/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $35.24 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $84.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2021 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $70.32 | General |
| Category: Neurology | ||||||
| 09/28/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $99.97 | General |
| Category: PRIMARY CARE | ||||||
| 10/27/2020 | BioMarin Pharmaceutical Inc. | Brineura (Biological) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: CLN 2 | ||||||
| 09/25/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/13/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2020 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA, AVONEX | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: NEUROLOGY | ||||||
| 01/07/2020 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 156 | 190 | $65,625 | $17,200 |
| 2022 | 7 | 189 | 197 | $83,720 | $16,039 |
| 2021 | 8 | 411 | 456 | $225,774 | $47,533 |
| 2020 | 9 | 428 | 448 | $171,461 | $36,864 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 74 | 75 | $41,496 | $9,329 | 22.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 48 | $13,656 | $4,456 | 32.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 36 | $7,172 | $2,221 | 31.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 20 | 31 | $3,301 | $1,194 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 36 | $21,528 | $3,857 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 60 | $25,440 | $3,816 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 44 | $13,244 | $2,330 | 17.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $7,192 | $2,120 | 29.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 12 | $8,460 | $1,952 | 23.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $4,284 | $1,235 | 28.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 19 | $3,572 | $729.32 | 20.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 110 | 129 | $77,358 | $16,749 | 21.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 136 | $58,616 | $11,924 | 20.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 55 | 55 | $30,635 | $6,523 | 21.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 33 | 33 | $24,288 | $5,214 | 21.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 45 | $13,635 | $2,775 | 20.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 25 | 25 | $9,275 | $2,105 | 22.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 15 | $6,495 | $1,238 | 19.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 18 | 18 | $5,472 | $1,004 | 18.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 96 | 105 | $48,720 | $10,147 | 20.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 123 | 130 | $44,980 | $9,296 | 20.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 37 | 37 | $19,351 | $4,243 | 21.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 26 | 26 | $17,186 | $4,173 | 24.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 35 | 37 | $12,802 | $3,084 | 24.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 51 | $12,138 | $2,386 | 19.7% |
About Dr. Oscar Sanchez, MD
Dr. Oscar Sanchez, MD is a Neurology healthcare provider based in Medford, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063412427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Oscar Sanchez, MD has received a total of $4,313 in payments from pharmaceutical and medical device companies, with $596.05 received in 2024. These payments were reported across 165 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($4,240).
As a Medicare-enrolled provider, Sanchez has provided services to 1,184 Medicare beneficiaries, totaling 1,291 services with total Medicare billing of $117,636. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Medford, OR
- Active Since 07/28/2005
- Last Updated 02/27/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1063412427
Products in Payments
- TYSABRI (Biological) $436.03
- DISEASE STATE (Drug) $321.71
- ANDEXXA (Biological) $267.46
- BOTOX (Biological) $204.95
- VYVGART (Drug) $170.08
- SOLIRIS (Drug) $142.52
- ENROUTE Transcarotid Neuroprotection System (Device) $133.12
- Mavenclad (Biological) $125.13
- VYVGART HYTRULO (Drug) $125.00
- AJOVY (Drug) $120.21
- Rebif (Biological) $118.19
- LEMTRADA (Drug) $103.96
- NURTEC ODT (Drug) $99.97
- XCOPRI (Drug) $97.02
- UBRELVY (Drug) $95.58
- LINQ II (Device) $89.94
- Aimovig (Biological) $89.88
- SOLIRIS (Biological) $81.43
- Briviact (Drug) $79.95
- Xadago (Drug) $79.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Medford
Walter Carlini, Md, MD
Neurology — Payments: $588,979
Minji Kim, M.d, M.D
Neurology — Payments: $10,876
Pawani Sachar, M.d, M.D
Neurology — Payments: $2,620
Dr. Christopher Dardis, Md, MD
Neurology — Payments: $1,929
Tyler Scott, D.o, D.O
Neurology — Payments: $871.33
Curtis Delplanche, O.d., M.d, O.D., M.D
Neurology — Payments: $414.86